NasdaqCM - Delayed Quote USD
Sol-Gel Technologies Ltd. (SLGL)
Tune into live earnings calls Now streaming directly on quote pages.
7.72
+0.06
+(0.78%)
At close: May 7 at 4:00:02 PM EDT
7.72
0.00
(0.00%)
Pre-Market: 4:43:38 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -2.3 | -10.1 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -1.75 | -1.6 | -1.9 | -0.5 |
| EPS Actual | -1.7 | -2.3 | 0.7 | -0.1 |
| Difference | 0.05 | -0.7 | 2.6 | 0.4 |
| Surprise % | 2.86% | -43.75% | 136.84% | 80.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SLGL | -- | -- | -- | -- |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Downgrade | Raymond James: Strong Buy to Outperform | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Maintains | Raymond James: Strong Buy to Strong Buy | 8/11/2023 |
Related Tickers
PTIX Protagenic Therapeutics, Inc.
3.0400
-7.32%
PBM Psyence Biomedical Ltd.
4.2750
-3.72%
LIMN Liminatus Pharma, Inc.
6.00
-3.13%
IBO Impact BioMedical Inc.
0.5102
-16.33%
FULC Fulcrum Therapeutics, Inc.
5.07
-5.23%
KTTA Pasithea Therapeutics Corp.
1.1300
-25.66%
SPRC SciSparc Ltd.
0.3100
-0.03%
GLMD Galmed Pharmaceuticals Ltd.
1.2900
-11.64%
HEPA Hepion Pharmaceuticals, Inc.
0.3900
+20.41%
ZVSA ZyVersa Therapeutics, Inc.
0.6848
+24.24%